04943nam 2200613Ia 450 991045748690332120200520144314.088-97419-08-9(CKB)2550000000083051(EBL)837840(OCoLC)773565234(SSID)ssj0000633222(PQKBManifestationID)11445828(PQKBTitleCode)TC0000633222(PQKBWorkID)10617043(PQKB)11154902(MiAaPQ)EBC837840(Au-PeEL)EBL837840(CaPaEBR)ebr10572354(EXLCZ)99255000000008305120120705d2011 uy 0engur|n|---|||||txtccrChemotherapy regimens in rare solid tumors[electronic resource] /Alessandro GommandoneTorino SEEd20111 online resource (144 p.)Description based upon print version of record.88-97419-07-0 Includes bibliographical references.Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: DoxorubicinAnaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-FluorouracilGEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancersVulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): TrabectedinUterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVBTesticular tumors: VeIP (rescue regimen)Rare tumors are an increasing problem in oncology. Aim of this book is to offer a help in spreading the knowledge of low-incidence tumors in oncology. Each chapter provides brief information about the epidemiology of and clinical aspects for every RT; and, following each chemotherapy schedule, we report a short description of the hematologic toxicities related to the treatment.TumorsChemotherapyElectronic books.Tumors.Chemotherapy.617.4/4617.44Comandone Alessandro903683MiAaPQMiAaPQMiAaPQBOOK9910457486903321Chemotherapy regimens in rare solid tumors2020004UNINA